Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Chan

Showing results (1221-1230 of 1,346) with videos related to

Pageof 135
Sort By:
ESMO Open|April 16, 2024
ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancerP M Carrera, G Curigliano, D Santini, et al.
BMJ Open|May 16, 2022
Telehealth cancer-related fatigue clinic model for cancer survivors: a pilot randomised controlled trial protocol (the T-CRF trial)Rahul Ladwa, Elizabeth P Pinkham, Laisa Teleni, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2023
Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidinesJoline S J Lim, Samuel G W Ow, Andrea L A Wong, et al.
Clinical and Translational Radiation Oncology|June 12, 2025
Systematic review of the tools and outcomes for the assessment of acute radiation dermatitis severityPartha Patel, Syed Minhaj Rahman, Tara Behroozian, et al.
BMC Research Notes|June 3, 2025
A single presumptive deworming may not suffice to reduce the burden of intestinal parasitic infections during pregnancy in rural Amhara, EthiopiaKalkidan Yibeltal, Firehiwot Workneh, Nebiyou Fasil, et al.
Leukemia|October 30, 2012
The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivoS C Nabinger, X J Li, B Ramdas, et al.
ESMO Open|March 11, 2025
Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testingS W Cheo, J J Zhao, P Y Ong, et al.
Cell Reports|December 3, 2014
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven LeukemogenesisAnindya Chatterjee, Joydeep Ghosh, Baskar Ramdas, et al.
International Journal of Cancer|June 21, 2025
Patient-reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trialsBradley D Menz, Natansh D Modi, Ahmad Y Abuhelwa, et al.
Molecular Pharmaceutics|December 9, 2014
Methotrexate-conjugated PEGylated dendrimers show differential patterns of deposition and activity in tumor-burdened lymph nodes after intravenous and subcutaneous administration in ratsLisa M Kaminskas, Victoria M McLeod, David B Ascher, et al.
Pageof 135

Showing results (1221-1230 of 1,346) with videos related to

Sort By:
Pageof 135
ESMO Open|April 16, 2024
ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancerP M Carrera, G Curigliano, D Santini, et al.
BMJ Open|May 16, 2022
Telehealth cancer-related fatigue clinic model for cancer survivors: a pilot randomised controlled trial protocol (the T-CRF trial)Rahul Ladwa, Elizabeth P Pinkham, Laisa Teleni, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2023
Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidinesJoline S J Lim, Samuel G W Ow, Andrea L A Wong, et al.
Clinical and Translational Radiation Oncology|June 12, 2025
Systematic review of the tools and outcomes for the assessment of acute radiation dermatitis severityPartha Patel, Syed Minhaj Rahman, Tara Behroozian, et al.
BMC Research Notes|June 3, 2025
A single presumptive deworming may not suffice to reduce the burden of intestinal parasitic infections during pregnancy in rural Amhara, EthiopiaKalkidan Yibeltal, Firehiwot Workneh, Nebiyou Fasil, et al.
Leukemia|October 30, 2012
The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivoS C Nabinger, X J Li, B Ramdas, et al.
ESMO Open|March 11, 2025
Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testingS W Cheo, J J Zhao, P Y Ong, et al.
Cell Reports|December 3, 2014
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven LeukemogenesisAnindya Chatterjee, Joydeep Ghosh, Baskar Ramdas, et al.
International Journal of Cancer|June 21, 2025
Patient-reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trialsBradley D Menz, Natansh D Modi, Ahmad Y Abuhelwa, et al.
Molecular Pharmaceutics|December 9, 2014
Methotrexate-conjugated PEGylated dendrimers show differential patterns of deposition and activity in tumor-burdened lymph nodes after intravenous and subcutaneous administration in ratsLisa M Kaminskas, Victoria M McLeod, David B Ascher, et al.
Pageof 135